 On July 16, 2019, BiondVax Pharmaceuticals Ltd. BVXV announced that the previously announced rights offering was fully subscribed and the company raised gross proceeds of 20 million through the sale of 3,057,466 American Depository Shares ADSs and 18,298,898 ordinary shares. BiondVaxs largest shareholder, Angels Investment High Tech Ltd. which is wholly owned by Mr. Marius Nacht, fully subscribed for the entire allotment available to them and also exercised the option to purchase 2,203,640 ADSs and 141,538 ordinary shares that were not purchased by other shareholders. Thus, Angels Investment High Tech Ltd. total investment in the rights offering was 16.67 million, and the firm is now a controlling shareholder with a holding of approximately 42 of BiondVax. 